Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Cramer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|April 5, 2011
Function of the activated protein C (APC) autolysis loop in activated FVIII inactivationThomas J Cramer, Andrew J Gale
Thrombosis and Haemostasis|November 26, 2011
The anticoagulant function of coagulation factor VThomas J Cramer, Andrew J Gale
Pathophysiology of Haemostasis and Thrombosis|May 27, 2010
Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor VaThomas J Cramer, John H Griffin, Andrew J Gale
The Journal of Biological Chemistry|April 22, 2008
Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor VAndrew J Gale, Thomas J Cramer, Diana Rozenshteyn, et al.
Microcirculation (New York, N.Y. : 1994)|June 20, 2017
The hypertension of hemophilia is associated with vascular remodeling in the jointRichard F W Barnes, Thomas J Cramer, Tudor H Hughes, et al.
Blood Cells, Molecules & Diseases|February 9, 2016
Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent maleThomas J Cramer, Kristin Anderson, Karanjia Navaz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2019
Joint Bleeding Tendencies in Adult Patients With Hemophilia: It's Not All PharmacokineticsJenny Y Zhou, Richard F W Barnes, Gary Foster, et al.
Plos One|August 16, 2014
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein CAnnette von Drygalski, Vikas Bhat, Andrew J Gale, et al.
International Journal of Hypertension|December 15, 2016
The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort StudyRichard F W Barnes, Thomas J Cramer, Afrah S Sait, et al.
Blood Advances|August 11, 2020
An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanismsAnnette von Drygalski, Vikas Bhat, Andrew J Gale, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|April 5, 2011
Function of the activated protein C (APC) autolysis loop in activated FVIII inactivationThomas J Cramer, Andrew J Gale
Thrombosis and Haemostasis|November 26, 2011
The anticoagulant function of coagulation factor VThomas J Cramer, Andrew J Gale
Pathophysiology of Haemostasis and Thrombosis|May 27, 2010
Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor VaThomas J Cramer, John H Griffin, Andrew J Gale
The Journal of Biological Chemistry|April 22, 2008
Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor VAndrew J Gale, Thomas J Cramer, Diana Rozenshteyn, et al.
Microcirculation (New York, N.Y. : 1994)|June 20, 2017
The hypertension of hemophilia is associated with vascular remodeling in the jointRichard F W Barnes, Thomas J Cramer, Tudor H Hughes, et al.
Blood Cells, Molecules & Diseases|February 9, 2016
Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent maleThomas J Cramer, Kristin Anderson, Karanjia Navaz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2019
Joint Bleeding Tendencies in Adult Patients With Hemophilia: It's Not All PharmacokineticsJenny Y Zhou, Richard F W Barnes, Gary Foster, et al.
Plos One|August 16, 2014
An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein CAnnette von Drygalski, Vikas Bhat, Andrew J Gale, et al.
International Journal of Hypertension|December 15, 2016
The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort StudyRichard F W Barnes, Thomas J Cramer, Afrah S Sait, et al.
Blood Advances|August 11, 2020
An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanismsAnnette von Drygalski, Vikas Bhat, Andrew J Gale, et al.
Pageof 2